banner-biblioteca-3
Banner-pesquisa
endodebate-biblioteca-bt-diacordis1
endodebate-biblioteca-bt-01
endodebate-biblioteca-bt-02
endodebate-biblioteca-bt-paciente-diabetes
momento-diabetes

Aulas endoDEBATE 2020 DIGIT@L

endodebate-biblioteca-bt-aula01
endodebate-biblioteca-bt-aula02
endodebate-biblioteca-bt-aula03
endodebate-biblioteca-bt-aula04
endodebate-biblioteca-bt-aula05
endodebate-biblioteca-bt-aula06

Acesse os artigos científicos sobre células-tronco em diabetes publicados pela equipe da USP - Ribeirão Preto

1. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC.

JAMA. 2009 Apr 15;301(15):1573-9.

Link: https://bit.ly/2AObOln

 

2. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC.

JAMA. 2009 Apr 15;301(15):1573-9.

Link: https://bit.ly/2AObOln

 

3. Teplizumab in Relatives at Risk for Type 1 Diabetes.

Couri CE, Malmegrim KCR, Oliveira MC.

N Engl J Med. 2019 Nov 7;381(19):1879.

Link: https://bit.ly/302DEmq

 

4. Immunological Applications of Stem Cells in Type 1 Diabetes

Paolo Fiorina, Julio Voltarelli, Nicholas Zavazava

Endocrine Review 2011 Dec;32(6):725-54.

Link: https://bit.ly/2W7EsFM

 

5. New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement

Carlos E B Couri, Kelen C R Malmegrim, Maria C Oliveira

Front Immunol 2018 May 17;9: 1086.

Link: https://bit.ly/2W6aWQH

 

6. Teplizumab in Relatives at Risk for Type 1 Diabetes.

Couri CE, Malmegrim KCR, Oliveira MC.

N Engl J Med. 2019 Nov 7;381(19):1879.

Link: https://bit.ly/302DEmq

 

7. Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.

Malmegrim KC, de Azevedo JT, Arruda LC, Abreu JR, Couri CE, de Oliveira GL, Palma PV, Scortegagna GT, Stracieri AB, Moraes DA, Dias JB, Pieroni F, Cunha R, Guilherme L, Santos NM, Foss MC, Covas DT, Burt RK, Simões BP, Voltarelli JC, Roep BO, Oliveira MC.

Front Immunol. 2017 Feb 22;8:167.

Link: https://bit.ly/2W9WN4K

 

8. Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy.

Penaforte-Saboia JG, Montenegro RM Jr, Couri CE, Batista LA, Montenegro APDR, Fernandes VO, Akhtar H, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Simões BP, Gomes MB, Oliveira MC.

Front Endocrinol (Lausanne). 2017 Nov 23;8:331. 

Link: https://bit.ly/324oShF

 

9. Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.

de Lima KA, de Oliveira GL, Yaochite JN, Pinheiro DG, de Azevedo JT, Silva WA Jr, Covas DT, Couri CE, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KC.

Stem Cell Res Ther. 2016 Jul 12;7(1):92

Link: https://bit.ly/2ZhvF61

 

10. Stem cell therapy for diabetes mellitus.

Voltarelli JC, Couri CE, Oliveira MC, Moraes DA, Stracieri AB, Pieroni F, Barros GM, Malmegrim KC, Simões BP, Leal AM, Foss MC.

Kidney Int Suppl (2011). 2011 Sep;1(3):94-98.

Link: https://bit.ly/2Zitf7e

 

11. DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.

Davanso MR, Caliari-Oliveira C, Couri CEB, Covas DT, de Oliveira Leal AM, Voltarelli JC, Malmegrim KCR, Yaochite JNU.

Inflammation. 2019 Apr;42(2):449-462.

Link: https://bit.ly/2ZZylEw

 

12. Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy.

Penaforte-Saboia JG, Couri CEB, Fernandes VO, Montenegro APDR, Batista LAA, Zajdenverg L, Negrato CA, Malmegrim KCR, Moraes DA, Dias JBE, Oliveira MC, Hussain A, Gomes MB, Montenegro RM Jr.

Front Endocrinol (Lausanne). 2019 Nov 19;10:747. 

Link: https://bit.ly/3gLqKQE

13. Stem cell-based therapies and immunomodulatory approaches in newly diagnosed type 1 diabetes.

Couri CE, Voltarelli JC.

Curr Stem Cell Res Ther. 2011 Mar;6(1):10-5.

Link: https://bit.ly/2ZmntBD

 

14. Autologous hematopoietic stem cell transplantation for type 1 diabetes.

Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK.

Ann N Y Acad Sci. 2008 Dec;1150:220-9.

Link: https://bit.ly/2DvGSaG

 

15. Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes.

Couri CE, de Oliveira MC, Simões BP.

Curr Diab Rep. 2012 Oct;12(5):604-11.

Link: https://bit.ly/2BSdL0S

 

16. Emerging Aspects of the Body Composition, Bone Marrow Adipose Tissue and Skeletal Phenotypes in Type 1 Diabetes Mellitus.

Carvalho AL, Massaro B, Silva LTPE, Salmon CEG, Fukada SY, Nogueira-Barbosa MH, Elias J Jr, Freitas MCF, Couri CEB, Oliveira MC, Simões BP, Rosen CJ, de Paula FJA.

J Clin Densitom. 2019 Jul-Sep;22(3):420-428.

Link: https://bit.ly/2W70mJ7

 

17. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration.

Couri CE, Foss MC, Voltarelli JC.

Braz J Med Biol Res. 2006 Oct;39(10):1271-80.

Link: https://bit.ly/32ixlyb

 

18. Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT.

Leal AM, Oliveira MC, Couri CE, Moraes DA, Stracieri AB, Pieroni F, Soares RD, Barros GN, Simões BP, Foss MC, Voltarelli JC.

Bone Marrow Transplant. 2012 Mar;47(3):467-8.

Link: https://go.nature.com/3gOFr5y

 

19. Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials.

Couri CE, Voltarelli JC.

Diabetol Metab Syndr. 2009 Oct 16;1(1):19.

Link: https://bit.ly/3gPX190

 

20. Autologous stem cell transplantation for early type 1 diabetes mellitus.

Couri CE, Voltarelli JC.

Autoimmunity. 2008 Dec;41(8):666-72.

Link: https://bit.ly/2ZjoEBq

 

21. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK.

JAMA. 2007 Apr 11;297(14):1568-76.

Link: https://bit.ly/2AN2PAW

 

22. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simões BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC.

JAMA. 2009 Apr 15;301(15):1573-9.

Link: https://bit.ly/2AObOln

 

23. Immunological Applications of Stem Cells in Type 1 Diabetes

Paolo Fiorina, Julio Voltarelli, Nicholas Zavazava

Endocrine Review 2011 Dec;32(6):725-54.

Link: https://bit.ly/2W7EsFM

endodebate-banner-telegram-2

Realização:

Marcas-Site-03
endoDebate © 2020. Todos os direitos reservados.